Clinical trial
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710 · NeurogesX, Industry · Completed
Key facts
| NCT number | NCT00034710 |
|---|---|
| Title | Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain |
| Official title | A Double-Blind Controlled Pilot Study of High-Dose Capsaicin Patches in the Treatment of Pain Associated With Postherpetic Neuralgia |
| Lead sponsor | NeurogesX, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuralgia, Pain, Peripheral Nervous System Diseases, Herpes Zoster |
| Intervention type | Drug |
| Interventions | Capsaicin Patch |
| Enrollment | 42 |
| Start date | Mar 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | May 2, 2002 |
| Last update posted | Feb 7, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: